Hepatitis B Virus
Findings from Spain, Taiwan and Italy describe new data in hepatitis B virus research
Published in Blood Weekly, May 11th, 2006
Study 1: According to recent research from Spain, adefovir dipivoxil is promising in lamivudine-resistant chronic hepatitis B virus (HBV) infections.
"Our aim was to evaluate the efficacy and safety of adding adefovir to lamivudine therapy for HBV-infected patients resistant to lamivudine," wrote J.B. Gornals and colleagues, University of Barcelona.
"Among 17 studied patients, 7 had chronic active HBV infection and 10 were posttransplant with HBV infection (9 with de novo HBV). They received lamivudine plus adefovir therapy for 2 years."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-05-11)
More Articles from Blood Weekly
- Aspergillus Ustus Outbreaks
Aspergillus ustus outbreak occurred among stem cell transplantation recipients - Stem Cell Research
Immortalized endothelial progenitor cells offer a way to study new vessel growth - Tissue Engineering
Bioengineered myocardial tissue grafts may improve damaged heart function - Type 1 Diabetes
Transplantation of islets into diabetic primates results in prolonged blood sugar improvement - Adverse Drug Reaction
Acute liver failure could be caused by imatinib mesylate - Angiology
Researchers from the United States, Scotland and People's Republic of China provide details of new studies and findings in the area of angiology - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
